Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7498-86-4

Post Buying Request

7498-86-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7498-86-4 Usage

Synthesis Reference(s)

Journal of the American Chemical Society, 78, p. 2469, 1956 DOI: 10.1021/ja01592a034

Check Digit Verification of cas no

The CAS Registry Mumber 7498-86-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,9 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7498-86:
(6*7)+(5*4)+(4*9)+(3*8)+(2*8)+(1*6)=144
144 % 10 = 4
So 7498-86-4 is a valid CAS Registry Number.
InChI:InChI=1/C16H13NO3/c1-10(16(18)19)20-17-15-13-8-4-2-6-11(13)12-7-3-5-9-14(12)15/h2-10H,1H3,(H,18,19)

7498-86-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(fluoren-9-ylideneamino)oxypropanoic acid

1.2 Other means of identification

Product number -
Other names 2-Fluoren-9-ylidenaminooxy-propionsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7498-86-4 SDS

7498-86-4Downstream Products

7498-86-4Relevant articles and documents

Camptothecin derivatives as chemoradiosensitizing agents

-

Page/Page column 36-37, (2008/06/13)

Camptothecin-based compounds are useful for treating a neoplasm in mammalian subjects by administering such compound to the subjects in combination with radiotherapy, i.e., the treatment of tumors with radioactive substances or radiation from a source external to the subject. Camptothecin-based compounds are modified by positioning at least one electron-affinic group around the camptothecin structure to enhance their value in combination with radiotherapy. New Camptothecin-based compounds are disclosed that are useful for treating cancer by administering the novel compounds alone or in combination with radiotherapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7498-86-4